Data / Federal rules / 2024-02322

Conforming Amendment Regarding the Veterinary Medicine Mobility Act of 2014

The Drug Enforcement Administration published this final rule in the Federal Register on February 8, 2024. It took effect on February 8, 2024.

SpecStream is the live web data engine for teams and agents. It reads every rule and proposed rule in the Federal Register each morning, and this page is that reading. Name your industry once and new rules, comment deadlines and effective dates arrive in your sheet, CRM, Slack or agent as they are published.

Get new rules for your industry

What the agency says

The Veterinary Medicine Mobility Act of 2014 (VMMA), which became law on August 1, 2014, amended the Controlled Substances Act to address separate registration requirements for veterinarians. The VMMA allows a veterinarian to transport and dispense controlled substances in the usual course of veterinary practice at a site other than the veterinarian's registered principal place of business or professional practice without obtaining a separate registration, subject to certain limitations. The Drug Enforcement Administration is amending its regulations to codify the VMMA. This rule merely conforms DEA regulations to statutory amendments of the Controlled Substances Act that have already taken effect and makes no substantive change to existing legal requirements.

Key facts

Document number: 2024-02322
Type: Final rule
Action: Final rule
Agency: Justice Department; Drug Enforcement Administration
Published: February 8, 2024
Takes effect: February 8, 2024
Dates: This final rule is effective on February 8, 2024.
Docket: Docket No. DEA-1043
Regulation ID (RIN): 1117-AB82
Code of Federal Regulations: 21 CFR 1301
Topics: Administrative practice and procedure; Drug traffic control; Exports; Imports; Security measures
Significant: Yes, under Executive Order 12866
Pages: 2

The document on federalregister.gov PDF

Other documents from the Drug Enforcement Administration

Document	Type	Published
Schedules of Controlled Substances: Temporary Placement of 7- Hydroxymitragynine and Mitragynine Pseudoindoxyl Above a Specified Threshold in Schedule I 2026-20943	Proposed rule	Oct 14
Schedules of Controlled Substances: Temporary Placement of MGM-15 and MGM-16 in Schedule I 2026-20942	Proposed rule	Oct 14
Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products 2026-20757	Final rule	Oct 9
Schedules of Controlled Substances: Placement of O-Desmethyltramadol in Schedule I; Correction 2026-20748	Final rule	Oct 9
Extension of Reexportation Period. 2026-20084	Proposed rule	Oct 1
Schedules of Controlled Substances: Placement of 4-Hydroxy-N,N-Diisopropyltryptamine (4-OH-DiPT), 5-Methoxy-alpha-Methyltryptamine (5-MeO-AMT), 5-Methoxy-N-Methyl-N-Isopropyltryptamine (5-MeO-MiPT), 5-Methoxy-N,N-Diethyltryptamine (5-MeO-DET), and N,N-Diisopropyltryptamine (DiPT) Into Schedule I 2026-19400	Proposed rule	Sep 23
Schedules of Controlled Substances: Placement of Diphenidine in Schedule I 2026-19231	Final rule	Sep 21
Schedules of Controlled Substances: Placement of Cipepofol in Schedule IV 2026-17536	Final rule	Aug 27

Everything from the Drug Enforcement Administration · Rules on administrative practice and procedure · Rules on drug traffic control · Rules on exports · Published in February 2024

Read from the Federal Register API, last updated 2026-10-23. The document on federalregister.gov is the official record; dates and dockets can change through later corrections. Free to reuse with credit to SpecStream under CC BY 4.0.